Machine Learning

HealthVerity's acquisition of Symphony Health unites clinical and commercial data, promising to shatter industry silos and accelerate medical breakthroughs.

New research reveals AI is not just hype for manufacturers. Early adopters see real value in months, leaving hesitant competitors far behind.

Innovative Dining Group used AI to capture 5,100+ missed calls and book 1,200+ tables, showcasing how automation is now a key ingredient for profit.

A new partnership aims to end the 'black box' era of crypto market making, forcing a shift from reputation to verifiable, data-driven performance.

HURST Jaws of Life and Elevat launch Captium IQ, an AI-powered system designed to ensure mission-critical rescue equipment is always ready for action.

With its 100th study launch and a perfect client retention rate, Atreo's agile RTSM platform is challenging the rigid, slow pace of traditional trial tech.

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

A new firm will underwrite a $400M fund, signaling a shift in patent finance toward specialized expertise and empowering small inventors.

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.

Germany's startups attracted €1.7B in Q1 2026, fueled by US investors and a massive bet on artificial intelligence, signaling a new era for its ecosystem.

BMW Group and Quantinuum expand their landmark collaboration, leveraging next-gen quantum computers to revolutionize materials for future electric and fuel cell vehicles.

A new biotech emerges with a promising, late-stage gene therapy for Sanfilippo syndrome, offering a potential lifeline for children with no other options.

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

Broker-dealer AmerX launches an equity research division, integrating its NYSE floor presence with a new focus on physical AI to deliver actionable insights.

A $20M investment in Seedli Capital signals growing institutional belief in tokenized real-world assets. But can the Web3 world meet TradFi's demands?

Dubai-based Surexo surpasses 500,000 users, leveraging AI and a security-first approach to expand its fintech footprint across 30+ countries.

With new backing from Catchment Capital and Stellus, Phoenix-based Vertech is poised to expand its critical role in automating America's industries.

UK biotech Cytospire Therapeutics secures major funding to push its safer, more selective gamma delta T-cell engager into clinical trials for solid tumors.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.

A new AI tool promises to turn complex financial contracts from a multi-hour headache into minutes of work, reducing risk and unlocking strategic value.